CTLA4 and malignant colon neoplasm: In other words, NDV can enhance the capability of CTLA-4 inhibitor on conquering tumor metastasis and improving long-term survival of mice with colon cancer or melanoma, by increasing tumor infiltration with activated lymphocytes, and systemic tumor inflammatory effects [66].